| scholarly article | Q13442814 |
| P50 | author | Tobias L. Ross | Q42855339 |
| P2093 | author name string | Hanno Schieferstein | |
| Johannes M Postema | |||
| Katharina Stockhofe | |||
| P2860 | cites work | Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles. | Q51826368 |
| Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging. | Q53102732 | ||
| Synthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical application. | Q53178228 | ||
| 18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly | Q57185181 | ||
| Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging | Q57340718 | ||
| Nanoparticle-Mediated Local and Remote Manipulation of Protein Aggregation | Q60482252 | ||
| In Vivo Biodistribution of Amino-Functionalized Ceria Nanoparticles in Rats Using Positron Emission Tomography | Q60620005 | ||
| Tracing nanoparticles in vivo: a new general synthesis of positron emitting metal oxide nanoparticles by proton beam activation | Q84945341 | ||
| Radiolabeled nanogels for nuclear molecular imaging | Q86169090 | ||
| Imaging in the era of molecular oncology | Q24650949 | ||
| A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 | ||
| Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes | Q28384090 | ||
| PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice | Q28469301 | ||
| Modular strategies for PET imaging agents | Q33643481 | ||
| PET/NIRF/MRI triple functional iron oxide nanoparticles | Q33727232 | ||
| In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent | Q33833089 | ||
| cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. | Q33834952 | ||
| Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET. | Q34632453 | ||
| PET Imaging and Biodistribution of Silicon Quantum Dots in Mice | Q34909815 | ||
| The dawning era of polymer therapeutics | Q35128900 | ||
| Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications | Q35897573 | ||
| Molecular imaging with copper-64. | Q35937285 | ||
| Polymer conjugates as anticancer nanomedicines | Q36561667 | ||
| Exploiting the enhanced permeability and retention effect for tumor targeting | Q36578875 | ||
| Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer | Q36625683 | ||
| An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution | Q36870970 | ||
| Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis | Q37070582 | ||
| Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes | Q37136682 | ||
| Small molecule receptors as imaging targets | Q37216352 | ||
| The advantages of nanoparticles for PET. | Q37616923 | ||
| Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. | Q37671146 | ||
| Iodine-124: a promising positron emitter for organic PET chemistry | Q37739199 | ||
| Maturation of a key resource - the germanium-68/gallium-68 generator: development and new insights | Q38018661 | ||
| Emerging role of radiolabeled nanoparticles as an effective diagnostic technique | Q38027231 | ||
| Polymer therapeutics-prospects for 21st century: the end of the beginning | Q38043776 | ||
| Facile method to radiolabel glycol chitosan nanoparticles with (64)Cu via copper-free click chemistry for MicroPET imaging | Q39166413 | ||
| Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution | Q39406359 | ||
| Gold nanoparticle probes: design and in vitro applications in cancer cell culture | Q39445853 | ||
| In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts | Q39694300 | ||
| Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation | Q39737140 | ||
| Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging | Q39828250 | ||
| In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. | Q40223991 | ||
| 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation | Q40401329 | ||
| microPET-based biodistribution of quantum dots in living mice | Q42067780 | ||
| Biocompatible nanocomposite for PET/MRI hybrid imaging | Q42419241 | ||
| Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice | Q42723945 | ||
| 72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging | Q42937328 | ||
| Low temperature synthesis of ZnS and CdZnS shells on CdSe quantum dots | Q43048017 | ||
| Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. | Q43153036 | ||
| PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography | Q43718606 | ||
| Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers | Q44287754 | ||
| Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography. | Q46020345 | ||
| Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications | Q46311331 | ||
| 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. | Q46380200 | ||
| Mesoporous silica nanoparticle pretargeting for PET imaging based on a rapid bioorthogonal reaction in a living body | Q46410647 | ||
| Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle | Q46817247 | ||
| Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. | Q47377302 | ||
| A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. | Q47585799 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | nanoparticle | Q61231 |
| P1104 | number of pages | 27 | |
| P304 | page(s) | 392-418 | |
| P577 | publication date | 2014-04-02 | |
| P1433 | published in | Pharmaceuticals | Q15750667 |
| P1476 | title | Radiolabeling of Nanoparticles and Polymers for PET Imaging | |
| P478 | volume | 7 |
| Q47315999 | A topological analysis of targeted In-111 uptake in SPECT images of murine tumors. |
| Q36783691 | Biodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP). |
| Q47362426 | Dendrimer-based contrast agents for PET imaging |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q31122060 | Immobilization of iron oxide nanoparticles within alginate nanogels for enhanced MR imaging applications |
| Q39017070 | Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy |
| Q30393523 | Molecular Imaging of Pancreatic Cancer with Antibodies |
| Q89633809 | Nanocarriers as Magic Bullets in the Treatment of Leukemia |
| Q64819927 | Neurotheranostics as personalized medicines |
| Q26822871 | Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects |
| Q36514481 | Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation |
| Q60184483 | Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications |
| Q60303017 | Peptide-nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? |
| Q45925924 | Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy. |
| Q35532147 | Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging |
| Q88849351 | Radiolabeled Dendrimers for Nuclear Medicine Applications |
| Q38755295 | Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? |
| Q38269215 | Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents. |
| Q39429246 | Theranostic and nanotheranostic probes in nuclear medicine |
| Q90567994 | pH-Responsive Carboxymethylcellulose Nanoparticles for 68Ga-WBC Labeling in PET Imaging |
| Q58101078 | pH-Sensitive Co-Adsorption/Release of Doxorubicin and Paclitaxel by Carbon Nanotube, Fullerene, and Graphene Oxide in Combination with -isopropylacrylamide: A Molecular Dynamics Study |
Search more.